Fenning RS, Burgert ME, Hamamdzic D, Peyster EG, Mohler ER, Kangovi S, Jucker BM, Lenhard SC, Macphee CH, Wilensky RL (2015) <br />Atherosclerotic plaque inflammation varies between vascular sites and correlates with response to inhibition of lipoprotein-associated phospholipase A2<br /><i>J Am Heart Assoc</i> <b>4</b>: <br /><br />Wilensky RL, Shi Y, Mohler ER, 3rd, Hamamdzic D, Burgert ME, Li J, Postle A, Fenning RS, Bollinger JG, Hoffman BE, Pelchovitz DJ, Yang J, Mirabile RC, Webb CL, Zhang L, Zhang P, Gelb MH, Walker MC, Zalewski A, Macphee CH (2008) <br />Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development<br /><i>Nat Med</i> <b>14</b>: 1059<br /><br />